Skip to main content

Advertisement

Table 3 Time period of clinically useful contrast enhancement after CA injection

From: Endocardial border delineation capability of a novel multimodal polymer-shelled contrast agent

CA (injected dose) Clinically useful time period
SonoVue (1.5 ml) 20–40 s
Polymer-shelled CA (1.5 ml) 0–20 s
Polymer-shelled CA (3 ml) 0–20 s
Polymer-shelled CA (5 ml) 20–40 s
  1. CA = contrast agent.